Literature DB >> 11191060

Neuropilin is a mediator of angiogenesis.

H Q Miao1, M Klagsbrun.   

Abstract

Neuropilin is both a receptor for semaphorins, which are mediators of neuronal guidance, and for VEGF, an angiogenesis factor. While the function of neuropilin in the nervous system has been characterized, its role in angiogenesis is only beginning to be elucidated. This article reviews some of the structural and functional features of neuropilin and presents the experimental evidence showing that it is a mediator of angiogenesis. In particular, we show that neuropilin and its soluble isoforms regulate tumor angiogenesis and subsequent tumor growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191060     DOI: 10.1023/a:1026579711033

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  30 in total

Review 1.  Molecular control of arterial-venous blood vessel identity.

Authors:  Ralf H Adams
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

2.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

Authors:  Christiana Ruhrberg; Holger Gerhardt; Matthew Golding; Rose Watson; Sofia Ioannidou; Hajime Fujisawa; Christer Betsholtz; David T Shima
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

3.  Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.

Authors:  Monika Edelbauer; Dipak Datta; Ingrid H C Vos; Aninda Basu; Maria P Stack; Marlies E J Reinders; Masayuki Sho; Katiana Calzadilla; Peter Ganz; David M Briscoe
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

Review 4.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

5.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.

Authors:  Ingeborg Stalmans; Yin-Shan Ng; Richard Rohan; Marcus Fruttiger; Ann Bouché; Ali Yuce; Hajime Fujisawa; Bart Hermans; Moshe Shani; Sandra Jansen; Dan Hicklin; David J Anderson; Tom Gardiner; Hans-Peter Hammes; Lieve Moons; Mieke Dewerchin; Désiré Collen; Peter Carmeliet; Patricia A D'Amore
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

6.  Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.

Authors:  Shokoufeh Shahrabi-Farahani; Marina Gallottini; Fabiana Martins; Erik Li; Dayna R Mudge; Hironao Nakayama; Kyoko Hida; Dipak Panigrahy; Patricia A D'Amore; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2016-02-11       Impact factor: 4.307

Review 7.  Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?

Authors:  Dan G Duda; Rakesh K Jain
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

8.  Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.

Authors:  Marie-Astrid Hervé; Hélène Buteau-Lozano; Roger Vassy; Ivan Bieche; Guillaume Velasco; Marika Pla; Gérard Perret; Samia Mourah; Martine Perrot-Applanat
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

9.  Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells.

Authors:  Stephan Schiekofer; Kurt Belisle; Gennaro Galasso; Jochen G Schneider; Bernhard O Boehm; Timo Burster; Gerd Schmitz; Kenneth Walsh
Journal:  Angiogenesis       Date:  2008-05-20       Impact factor: 9.596

10.  Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc.

Authors:  Sotonye K Tolofari; Stephen M Richardson; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2010-01-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.